PeraHealth

Charlotte, NC, USA All United States companies → — Founded 2008

Clinical AI Platform Healthcare Analytics / BI

Critical Care Emergency Medicine Hospital Medicine

Clinical Decision Support & Reference Triage & ER/ICU AI

Acquired

Claim this company

About PeraHealth

PeraHealth was a healthcare AI company known for its predictive analytics platform, primarily the Rothman Index. This FDA-cleared solution leverages real-time electronic health record (EHR) data, including vital signs, nursing assessments, and lab results, to calculate a patient’s acuity score. The Rothman Index provides clinicians with a comprehensive and continuously updated view of a patient’s physiological condition, enabling earlier identification of patient deterioration.

The company’s software solutions aimed to transform clinical decision support and improve the efficiency of healthcare delivery. By providing real-time and predictive analytics, PeraHealth’s tools helped healthcare providers identify at-risk patients sooner, leading to earlier intervention, improved quality of care, and reduced costs. The Rothman Index has been validated for use with neonatal, pediatric, and adult patients across various hospital settings, including emergency departments, general wards, and intensive care units. Its applications included reducing in-hospital mortality, decreasing unplanned transfers to the ICU, and facilitating more timely palliative care consults.

Focus Areas

predictive analytics clinical decision support patient surveillance real-time patient acuity healthcare data intelligence early warning systems

Business Intelligence

Technology

Cloud-native (Google Cloud), machine learning-powered, integrates with major EHR vendors

What Physicians Need to Know

Predictive Analytics & Real-time Clinical Surveillance

PeraHealth's core offering is real-time predictive analytics through its Rothman Index, an FDA-cleared patient acuity score. This system continuously monitors patient data from EHRs to identify at-risk patients sooner, often hours or days before traditional vital-signs-based warning systems.

Rothman Index (RI)

The Rothman Index is a universal, disease-agnostic patient score (0-100) derived from 26 clinical variables including labs, vitals, and nursing assessments. It provides a continuous measure of a patient's condition, trended over time, and is integrated into the EHR. A decrease in the score correlates to a decrease in patient health.

Sepsis Detection

PeraHealth's Rothman Index assists with early prediction of sepsis, providing clinicians with more time to intervene. It is designed to capture physiological deterioration that precedes sepsis, allowing for interventions to prevent its progression and has been shown to reduce sepsis mortality.

ICU Optimization & Mortality/Length of Stay/Readmission Reduction

The Rothman Index helps optimize ICU bed utilization, prioritize patient bedside visits, and improve patient flow. It has been proven to reduce in-hospital mortality (by as much as 30%), unplanned transfers to the ICU, length of stay, and readmissions.

Palliative Care Consults

The Rothman Index can identify patients who may benefit from palliative care interventions, potentially decreasing costs and reducing length of stay.

Clinical Decision Support & AI/Machine Learning

PeraHealth's platform provides actionable insights and objective decision support by synthesizing large amounts of real-time EHR data. The company leverages machine learning and AI in healthcare to analyze vast datasets, recognize patterns, and make predictions, enhancing clinical decision-making.

Physician Tip

For physicians, PeraHealth's solutions, particularly the Rothman Index, offer a clear, continuous, and objective measure of patient condition, integrated directly into the EHR. This allows for quick visualization of a patient's full picture, enabling earlier detection of subtle deterioration and timely intervention. The system acts as a 'second pair of eyes,' augmenting bedside clinicians by providing real-time alerts and insights without requiring additional documentation. This proactive approach can lead to improved patient outcomes, reduced mortality, and more efficient resource allocation, including better ICU utilization and appropriate palliative care referrals.

PeraHealth's solutions are designed for seamless integration with all major Electronic Health Record (EHR) vendors, including Epic, Cerner, and Meditech. This leverages existing EHR investments and utilizes real-time data for predictive analytics. The platform is also available as a Google Cloud-based version, further enhancing its accessibility and scalability.

Products by PeraHealth

No products listed for this company yet. Know of one? Suggest it →

What the Web Says

PeraHealth, acquired by Spacelabs Healthcare in 2023, develops predictive enterprise software based on the Rothman Index, an FDA-cleared solution that quantifies patient acuity to help clinicians identify patient deterioration sooner. The company's products are designed to improve patient outcomes by leveraging EHR data and predictive analytics. While the product receives positive recognition for its impact on patient safety and clinical outcomes, employer reviews indicate a mixed to negative sentiment regarding company culture and management.

Overall: Mixed

Strengths

Great product that helps reduce in-hospital mortality and unplanned ICU transfers.
Utilizes the Rothman Index, an FDA-cleared and statistically validated patient acuity score.
Integrates existing EHR data with predictive analytics for real-time clinical surveillance.
Helps clinicians quickly visualize patient condition and identify at-risk patients.
Backed by numerous peer-reviewed articles.
Easy for customers to integrate the product into their daily routine.

Limitations

Poor company culture with employees stepping over each other for advancement.
Counterparts do not prioritize work hand-offs consistently.
Management issues, with some work left undone due to siding with higher-ranking managers.
Limited information available on recent employee reviews since the acquisition by Spacelabs Healthcare.
Lack of recent product reviews on major platforms like G2, Glassdoor, and Capterra specifically for PeraHealth's core product.

Based on reviews from: Indeed.com, Zippia, Forbes, PitchBook, pharmaphorum, Spacelabs Healthcare

Last updated: 2026-10-23

Videos

News, demos, and interviews about PeraHealth.

Loading videos...

Videos load interactively. If none appear, search YouTube for PeraHealth →

View all on YouTube

Press & Coverage

Pharmaphorum

FDA clears PeraHealth's lifesaving clinical surveillance tech

PeraHealth's PeraTrend, a predictive real-time clinical surveillance technology, received 510(k) clearance from the FDA, making it the first solution of its kind to achieve this. The technology uses the Rothman Index to quantify and visualize patient deterioration, risk, and improvement by combining EHR data.

2018-05

Business Wire

PeraHealth and BARDA Announce Partnership to Improve COVID-19 Patient Triage

PeraHealth partnered with the Biomedical Advanced Research and Development Authority (BARDA) to develop and install the Rothman Index Risk Triage tool. This tool, based on the FDA-cleared Rothman Index, aims to assess patient risk of severe outcomes in COVID-19 and non-COVID-19 patients upon emergency department entry.

2021-05

Business Wire

PeraHealth and Caregility Partner to Deliver Seamless Integration of Video-Based Consults with Real-Time Predictive Analytics

PeraHealth expanded its partnership with Caregility, integrating the Rothman Index with the Caregility Virtual Care Platform. This allows care teams to launch virtual visits directly from the Rothman Index patient dashboard, bridging actionable patient data with direct patient intervention.

2021-03

HCI Innovation Group

Spacelabs Buys Predictive Analytics Company PeraHealth

Spacelabs Healthcare acquired PeraHealth, a company known for its predictive enterprise software based on the Rothman Index. The acquisition aims to integrate PeraHealth's analytics into Spacelabs' digital health portfolio to enhance patient outcomes and reduce costs.

2023-02

Business Wire

PeraHealth Appoints Joseph Beals as Chief Executive Officer

Joseph Beals, PhD, MBA, was appointed Chief Executive Officer of PeraHealth. Having been with the company for over a decade, Beals has been instrumental in driving innovation across the organization.

2021-05

Business Wire

Shannon Health Upgrades to PeraHealth’s Google Cloud-Based Patient Surveillance Platform

Shannon Health upgraded to the latest Google Cloud-based version of PeraHealth's patient surveillance platform, integrating it with their Epic EMR system. This upgrade included the implementation of 'RI Triage' for Emergency Department use, developed with BARDA support.

2021-12

PeraHealth (via ctfassets.net)

PeraHealth’s Rothman Index Triggers Palliative Care, Decreases Costs

A study published by Yale New Haven Hospital in the Journal of Hospice and Palliative Nursing highlighted the clinical value of the Rothman Index in palliative care. The study showed that using the Rothman Index as a trigger for palliative care intervention led to a decrease in mean length of stay and lowered costs.

2017-06

HealthITOutcomes

Oconee Medical Center Selects PeraHealth’s PeraTrend Clinical Decision Support Tool

Oconee Medical Center implemented PeraHealth's PeraTrend clinical decision support tool to enhance healthcare quality. The tool, powered by the Rothman Index, extracts intelligence from EHRs to detect subtle changes in patient conditions, aiming for earlier medical intervention and improved outcomes.

2014-04

Frequently Asked Questions

What specific problems does PeraHealth's Rothman Index solve for physicians and healthcare administrators, particularly in areas like sepsis detection, ICU optimization, and mortality reduction?

PeraHealth's Rothman Index provides a real-time, continuous measure of patient condition, helping clinicians identify subtle deteriorations earlier. This predictive analytic tool aids in proactive sepsis detection, optimizes ICU resource allocation by identifying high-risk patients, and contributes to mortality reduction through timely interventions. It offers a standardized, objective metric that complements clinical judgment for improved patient outcomes.

How does PeraHealth integrate its predictive analytics and real-time clinical surveillance tools with existing EHR systems, and what level of IT support is typically required for implementation and ongoing maintenance?

PeraHealth's solutions are designed for seamless integration with major EHR systems through standard interfaces, ensuring that the Rothman Index and other insights are readily available within existing clinical workflows. The company provides comprehensive implementation support, including technical assistance and training, to minimize the burden on hospital IT departments. Ongoing maintenance is typically light, with PeraHealth offering continuous support and updates.

What are the key differentiators of PeraHealth's machine learning and AI approach compared to other healthcare analytics platforms, especially concerning patient acuity scoring and clinical decision support?

PeraHealth's Rothman Index is unique in its ability to synthesize diverse physiological data into a single, continuous acuity score, providing a holistic view of patient health. Unlike some other platforms, its AI and machine learning models are specifically trained and validated on extensive clinical datasets to provide highly accurate and actionable insights for clinical decision support, focusing on early warning and proactive intervention rather than just retrospective analysis.

Can you elaborate on PeraHealth's compliance with healthcare regulations (e.g., HIPAA, GDPR) and how your products address data security and patient privacy concerns?

PeraHealth prioritizes data security and patient privacy, adhering to all relevant healthcare regulations, including HIPAA and GDPR. Our products are built with robust security features, including data encryption, access controls, and audit trails, to protect sensitive patient information. We employ industry best practices for data handling and regularly undergo security assessments to ensure compliance and maintain the highest standards of data integrity.

What is the typical pricing structure for PeraHealth's solutions, and what kind of return on investment (ROI) can healthcare organizations expect in terms of length of stay reduction, readmission reduction, and improved resource utilization?

PeraHealth's pricing structure is typically subscription-based, tailored to the size and specific needs of the healthcare organization. While exact ROI varies, clients commonly report significant improvements in key metrics such as reduced length of stay, decreased readmission rates, and optimized resource utilization, including more efficient palliative care consults. These improvements translate into substantial cost savings and enhanced operational efficiency, often demonstrating a rapid return on investment.

What kind of partnerships does PeraHealth have with other healthcare technology companies or academic institutions, and how do these collaborations enhance your product offerings and research in AI in healthcare?

PeraHealth actively collaborates with leading healthcare technology companies and academic institutions to advance our product offerings and research in AI in healthcare. These partnerships facilitate the integration of our solutions with a broader ecosystem of healthcare tools, foster innovation in predictive analytics, and support ongoing research into new applications of the Rothman Index for improved patient care and outcomes.

What is PeraHealth's long-term vision and company stability? How does the company plan to evolve its products and services to address future challenges and advancements in healthcare AI?

PeraHealth is committed to continuous innovation and long-term stability, with a clear vision for evolving our products and services to meet the future demands of healthcare AI. We are actively investing in research and development to enhance our predictive analytics capabilities, expand into new clinical areas, and integrate emerging AI technologies. Our focus remains on empowering clinicians with actionable insights to improve patient care and operational efficiency, ensuring our continued relevance and leadership in the healthcare AI landscape.